Latest Biotechnology, Pharmaceutical and Healthcare News from SmartBrief

06:32 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "SmartBrief" found in our extensive news archives from over 250 global news sources.

More Information about SmartBrief on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SmartBrief for you to read. Along with our medical data and news we also list SmartBrief Clinical Trials, which are updated daily. BioPortfolio also has a large database of SmartBrief Companies for you to search.

Showing News Articles 1–25 of 3,600+ from SmartBrief

Friday 19th October 2018

Clarity is the antidote to anxiety, and therefore clarity is the preoccupation of the effective leader. If you do nothing else as a leader, be clear.

Marcus Buckingham, business consultant and author

Zika screening test by Co-Diagnostics earns CE mark

Co-Diagnostics' Logix Smart Zika test received CE-IVD marking, permitting the assay's sale in European Union states and other -More- 

Viseon's spinal surgery system wins FDA clearance

The FDA has given early-stage medical device company Viseon clearance for its minimally invasive Voyant system for accessing, -More- 

Final orders on 6 down-classifications issued by CDRH

The FDA's Center for Devices and Radiological Health has released final orders down-classifying six new device types, includi -More- 

Beddr debuts sleep monitoring wearable

Mountain View, Calif.-based Beddr has announced the release of its FDA-registered consumer wearable, SleepTuner, which monito -More- 

Germany grants reimbursement to Cardiac Dimensions' Carillon system

A permanent Diagnosis Related Group code has been granted by Germany's Institute for the Hospital Remuneration System to cove -More- 

Dexcom G6 CGM system wins Medicare coverage

Dexcom said the CMS has granted its G6 continuous glucose monitoring system coverage as a therapeutic CGM system for Medicare -More- 

Funding round pulls in around $5.8M for Finland-based Synoste

A round of financing has brought in approximately $5.8 million for Finland-based Synoste, which makes smart solutions for len -More- 

HJ Capital 1 to buy Atrium Medical's biosurgery business

Atrium Medical, a subsidiary of Getinge, has reached a deal to sell its soft tissue reinforcement devices-focused biosurgery  -More- 

Exact Sciences acquires Biomatrica

Exact Sciences has paid an undisclosed amount for San Diego-based Biomatrica, which makes blood and saliva collection tubes a -More- 

Abbott CEO bullish about FreeStyle Libre system

Abbott, which saw its medical device sales rise 8.4% to $2.82 billion in the third quarter, is making significant investments -More- 

Brazilian ethanol producer awarded $13M funding by BNDES

Ethanol producing company Companhia Agricola Usina Jacarezinho received $13 million from the Brazilian Development Bank.  -More- 

Biotech mosquito with smaller body size developed using CRISPR-Cas9

Scientists from University of California, Riverside used CRISPR-Cas9 technology to develop biotech mosquitoes that have decre -More- 

Novartis to pay $2.1B for drugmaker Endocyte

Swiss pharmaceutical company Novartis plans to buy US-based cancer-drug developer Endocyte for $2.1 billion.  -More- 

AbbVie to license Morphic's antifibrotic integrins

AbbVie and Morphic Therapeutic will work together to develop the latter's antifibrotic integrins to block transforming growth -More- 

Chinese biopharma initiates Phase I study for AML candidate

An early-stage study was launched in China by Hutchison China MediTech, or Chi-Med, to assess the preliminary efficacy, safet -More- 

Pain crises in sickle cell patients diminished with crizanlizumab

Based on post hoc analysis from its midstage SUSTAIN study, Novartis reported that nearly 36% of sickle cell patients treated -More- 

Rocket Pharma provides update on Fanconi anemia study in Spain

Rocket Pharmaceuticals unveiled updated long-term results from a Phase I/II study being conducted in Spain to assess its gene -More- 

Allergan to seek US approval for migraine drug

Dublin, Ireland-based Allergan plans to submit a marketing application for its migraine therapy ubrogepant to the US early ne -More- 

Keytruda, Inlyta combo shows benefits for kidney cancer patients

Statistically meaningful improvements in overall survival and disease progression were seen in patients with kidney cancer tr -More- 

FDA grants tentative approval to Teva's generic mifepristone

Teva Pharmaceutical Industries' generic version of mifepristone was granted tentative approval from the FDA.  -More- 

Thursday 18th October 2018

When small men begin to cast big shadows, it means the sun is about to set.

Lin Yutang, writer

EU OKs Thermo Fisher Scientific's NGS cancer test

European regulators have granted CE-IVD marking to Thermo Fisher Scientific's Oncomine Dx Target Test, a next-generation sequ -More- 

FDA won't finalize guidance on home-use device e-submission

The FDA said Wednesday in the Department of Health and Human Services Fall 2018 Unified Agenda of Federal Regulatory and Dere -More- 

FDA issues draft guidance on medical device cybersecurity

A draft guidance has been issued by the FDA in hopes of improving cybersecurity protection for medical devices through the up -More- 

Quick Search


News Quicklinks